Table 1.
Low and high population size estimates and estimated national HCV prevalences, by using a modified Workbook Method
| Population groups | Population size estimate | Anti-HCV prevalence estimate (%) | ||
|---|---|---|---|---|
| Low | High | Low | High | |
| HIV-positive IDU | 603 | 1017 | 91·60 | 95·90 |
| HIV-negative IDU | 7009 | 15 263 | 46·70 | 78·40 |
| HIV-positive MSM | 8670 | 17 573 | 9·10 | 10·50 |
| Haemophilia patients treated before 1992 | 1120 | 1120 | 42·50 | 50·70 |
| First-generation migrants from HCV-endemic countries | 1 130 512 | 1 130 512 | 0·40 | 1·64 |
| Individuals at low risk of infection | 11 766 036 | 11 783 607 | 0·00 | 0·12 |
IDU, Injecting drug user; MSM, men who have sex with men.